Patient education

Osteoporosis is a serious metabolic disorder of the bone that leads to fractures of the wrist, hip and vertebrae. In fact, it can be said that osteoporosis is a common disease, most of which is related to fractures that occur in people over 50 years. Osteoporotic fractures not only affect a patient's health and quality of life, but are also a major health problem given the economic and social costs associated with treatment and its side effects.

In addition, osteoporosis has a major impact on the general population. Economically, fractures due to osteoporosis impose a great burden. It is a very common disease that affects 150 to 200 million people worldwide. Overall, it is estimated that about 33% of women over the age of 50 suffer from osteoporosis. Although measures have been proposed to reduce this problem, osteoporosis is still not properly diagnosed and many patients remain untreated, even with fractures that can be diagnosed as osteoporosis. Worldwide, osteoporotic fractures affect one in three women and one in five men over the age of 50. This silent disease has many health and financial responsibilities for the health systems of developing and developed countries. Therefore, the development of national and long-term strategies to deal with this great threat and strengthen the health and well-being of society is of fundamental importance.


    Osteoporosis is a disease in which the bones become hollow and porous, weak and brittle.
    Osteoporosis is a silent disease, meaning that there are no symptoms until a bone is broken.
    Patients at high risk for fractures due to osteoporosis can reduce this risk with appropriate medication.
    Fractures are the most important complication of osteoporosis in old age.
    Fractures associated with osteoporosis often lead to pain, disability and reduced quality of life.
    Early detection of osteoporosis can reduce the risk of fractures, reduce family economic costs, reduce the likelihood of dependence and loss of independence, and reduce mortality in high-risk individuals.
    Do not stop taking osteoporosis medication (including calcium and vitamin D supplements) and consult your doctor if you are concerned.
    The use of osteoporosis treatments does not increase the risk of developing coronavirus.
    Social protection means staying at home and avoiding any face-to-face contact for 12 weeks.
    If you need to see a doctor or go to the hospital, make sure you are protected from exposure to the corona virus during your visit.
    In people with osteoporosis, it is important to prevent falls.
    Make the home environment safe to prevent people at risk from falling.
    If you are at risk of falling, consult your doctor for advice or protective equipment.